Abide Therapeutics, created in 2011 (United States), from 169 sister brands and 4958 competing brands. Abide Therapeutics is a brand of H. Lundbeck, listed on the stock exchange of Etats-Unis. Its International Securities Identification Number (ISIN) is DK0010287234. Abide Therapeutics is part of the Drug Manufacturers activity sector.